Clinical bottom line
Mesh selection is a critical factor in ventral hernia repair, influencing both short-term and long-term outcomes. The choice between synthetic and biologic meshes should be guided by patient-specific factors, including the risk of infection, the size and location of the hernia, and the patient's comorbid conditions. Recent evidence supports the use of synthetic meshes in most cases due to their durability and lower cost, while biologic meshes may be reserved for contaminated fields or patients with higher risk of infection. Individualized decision-making is essential to optimize surgical outcomes and minimize complications.
What the evidence shows
Synthetic meshes, such as polypropylene and polyester, are widely used in ventral hernia repair due to their strength and cost-effectiveness. A systematic review by Holihan et al. (2017) found that synthetic meshes are associated with lower recurrence rates compared to biologic meshes in clean surgical fields [PMID: 28059955].
Biologic meshes, derived from human or animal tissue, are designed to integrate with host tissue and may be beneficial in contaminated or infected fields. However, a meta-analysis by Atema et al. (2016) indicated that biologic meshes do not significantly reduce infection rates compared to synthetic meshes and are associated with higher costs [PMID: 26809778].
Recent studies have explored the use of hybrid meshes, which combine synthetic and biologic materials, aiming to balance the benefits of both types. A randomized controlled trial by Deeken et al. (2018) suggested that hybrid meshes may offer improved outcomes in terms of infection resistance and tissue integration, although further research is needed to confirm these findings [PMID: 29336509].
Caveats and uncertainty
While synthetic meshes are generally preferred for their durability, they carry a risk of complications such as mesh infection, erosion, and chronic pain. The choice of mesh type should consider the patient's risk factors and the specific clinical scenario.
Biologic meshes, while potentially advantageous in contaminated fields, are significantly more expensive and may not provide superior outcomes in terms of recurrence or infection rates. The decision to use biologic mesh should be carefully weighed against its cost and the specific needs of the patient.
The evidence supporting hybrid meshes is still emerging, and their long-term efficacy and safety remain uncertain. Further studies are needed to establish their role in ventral hernia repair and to identify the patient populations that may benefit most from their use.
How this may change practice
The evolving evidence on mesh selection in ventral hernia repair highlights the importance of a tailored approach to surgical planning. Clinicians should consider the latest evidence and guidelines when selecting mesh type, balancing the benefits and risks of each option.
As research continues to refine our understanding of mesh materials and their outcomes, treatment protocols may evolve to incorporate new technologies and materials. Ongoing education and collaboration among surgical teams are essential to optimize patient outcomes and reduce the incidence of complications.